Drug Testing Market Size To Reach $11.54 Billion By 2033

April 2026 | Report Format: Electronic (PDF)

Drug Testing Market Growth & Trends

The global drug testing market size is expected to reach USD 11.54 billion by 2033, registering a CAGR of 6.32% from 2026 to 2033, according to a new report by Grand View Research, Inc. The introduction of innovative tests, stringent regulation mandating drug testing, and growing substance abuse & addiction are some of the factors anticipated to foster market growth during the forecast period.

Drug abuse and addiction is a global problem, affecting millions of people. As per the World Drug Report published by UNODC, in 2019, around 35.0 million people were suffering from drug use disorders globally. Such a high rate of drug abuse and substance use disorders has created a major demand for innovative tests to prevent, treat, and manage such cases. Several key players operating in this space are introducing innovative and efficient products to meet this growing demand.

For instance, in June 2019, Quidel Corporation received the U.S. FDA’s 510(k) clearance to market its fluorescence immunoassay-Quidel Triage TOX Drug Screen, 94600. This is intended for detecting the presence of metabolites or drugs in urine. Moreover, in June 2020, Cordant Health Solutions offered video-observed oral fluid drug testing to help courts & government agencies to monitor participants during the COVID-19 pandemic. This aided in combating several challenges faced by people with substance abuse disorders during the pandemic.

Continuous government initiatives and implementation of strict substance abuse testing regulations to ensure safety have derived the demand for its testing products. In July 2020, the New Zealand government introduced a new bill that provides police the power to conduct random roadside drug testing of drivers to reduce impaired driving in the country. The new bill allows usage of oral fluid tests to check drivers for substances such as cocaine, ecstasy, cannabis, opiates, methamphetamine, and benzodiazepines. Also, in February 2020, the Directorate General of Civil Aviation in India introduced extensive tests for pilots and flight crew members for psychoactive substances such as opioids & cannabis to ensure safe air travel.

key Request a free sample copy or view report summary: Drug Testing Market Report

Drug Testing Market Report Highlights

By product, the consumables segment dominated the market and accounted for the largest revenue share of 33.21% in 2025. The services segment has been anticipated to grow at the fastest CAGR of 7.11% during the forecast period.
By sample, the urine samples segment dominated the market and accounted for the largest revenue share of 57.15% in 2025. Oral fluid samples have been anticipated to grow at the fastest CAGR of 8.71% during the forecast period.
By drug, the cannabis/marijuana segment dominated the market and accounted for the largest revenue share of 25.33% in 2025. Opioids has been anticipated to grow at a significant CAGR during the forecast period.
By end-use, the drug testing laboratories segment dominated the market in 2025. The workplace segment is projected to witness the fastest CAGR over the forecast period.
North America drug testing industry dominated and accounted for a 51.36% share in 2025. The U.S. drug testing industry is projected to grow significantly during the forecast period.
The Asia Pacific drug testing industry is expected to experience the fastest CAGR of 7.28% during the forecast period.